Assure Holdings Corp (IONM)
0.427
-0.05
(-10.29%)
USD |
NASDAQ |
May 17, 16:00
0.50
+0.07
(+17.10%)
After-Hours: 20:00
Assure Holdings Free Cash Flow: -5.044M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -5.044M |
September 30, 2023 | -6.976M |
June 30, 2023 | -7.602M |
March 31, 2023 | -5.753M |
December 31, 2022 | -7.494M |
September 30, 2022 | -9.307M |
June 30, 2022 | -10.02M |
March 31, 2022 | -13.58M |
December 31, 2021 | -13.37M |
September 30, 2021 | -10.97M |
June 30, 2021 | -9.538M |
March 31, 2021 | -5.035M |
December 31, 2020 | -3.503M |
September 30, 2020 | -3.46M |
June 30, 2020 | -2.483M |
March 31, 2020 | -3.723M |
December 31, 2019 | -4.276M |
September 30, 2019 | -2.826M |
June 30, 2019 | -1.996M |
March 31, 2019 | -1.162M |
December 31, 2018 | -0.657M |
September 30, 2018 | -1.518M |
June 30, 2018 | -2.577M |
March 31, 2018 | -3.498M |
December 31, 2017 | -2.715M |
Date | Value |
---|---|
September 30, 2017 | -1.291M |
June 30, 2017 | -0.6589M |
March 31, 2017 | 0.3019M |
December 31, 2016 | 0.3335M |
September 30, 2016 | -0.089M |
June 30, 2016 | 0.0644M |
March 31, 2016 | 0.0277M |
December 31, 2015 | -0.0426M |
September 30, 2015 | -0.0422M |
June 30, 2015 | -0.0438M |
March 31, 2015 | -0.0715M |
December 31, 2014 | -0.0593M |
September 30, 2014 | -0.0593M |
June 30, 2014 | -0.0569M |
March 31, 2014 | -0.0187M |
December 31, 2013 | -0.0075M |
September 30, 2013 | -0.0334M |
June 30, 2013 | -0.0628M |
March 31, 2013 | -0.1304M |
December 31, 2012 | -0.1678M |
September 30, 2012 | -0.1714M |
June 30, 2012 | -0.1495M |
March 31, 2012 | -0.094M |
December 31, 2011 | -0.0634M |
September 30, 2011 | -0.0598M |
Free Cash Flow Range, Past 5 Years
-13.58M
Minimum
Mar 2022
-1.996M
Maximum
Jun 2019
-6.682M
Average
-5.753M
Median
Mar 2023
Free Cash Flow Benchmarks
Science 37 Holdings Inc (DELISTED) | -73.70M |
ACADIA Pharmaceuticals Inc | 63.71M |
CymaBay Therapeutics Inc (DELISTED) | -72.98M |
Deciphera Pharmaceuticals Inc | -152.39M |
Larimar Therapeutics Inc | -36.32M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.222M |
Cash from Investing (Quarterly) | -0.112M |
Cash from Financing (Quarterly) | -0.177M |
Free Cash Flow Per Share (Quarterly) | -0.033 |
Free Cash Flow to Equity (Quarterly) | -0.431M |
Free Cash Flow to Firm (Quarterly) | 0.4225M |
Free Cash Flow Yield | -277.1% |